USD
+$0.00
(+0.00%
)At Close (As of Sep 3, 2025)
$9.70M
Market Cap
0.1
P/E Ratio
4.41
EPS
$1.90
52 Week High
$0.30
52 Week Low
LIFE SCIENCES
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$3M |
Total Revenue | $3M |
Cost Of Revenue | $6M |
Costof Goods And Services Sold | $6M |
Operating Income | -$44M |
Selling General And Administrative | $25M |
Research And Development | $5.9M |
Operating Expenses | $41M |
Investment Income Net | - |
Net Interest Income | $209K |
Interest Income | $254K |
Interest Expense | $45K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.2M |
Income Before Tax | $28M |
Income Tax Expense | -$3.5B |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $28M |
Comprehensive Income Net Of Tax | - |
Ebit | $28M |
Ebitda | $30M |
Net Income | $40M |
Field | Value (USD) |
---|---|
Total Assets | $31M |
Total Current Assets | $2.2M |
Cash And Cash Equivalents At Carrying Value | $1.2M |
Cash And Short Term Investments | $1.2M |
Inventory | $266K |
Current Net Receivables | $18K |
Total Non Current Assets | $28M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | - |
Investments | - |
Long Term Investments | $26M |
Short Term Investments | $347K |
Other Current Assets | $695K |
Other Non Current Assets | - |
Total Liabilities | $38M |
Total Current Liabilities | $35M |
Current Accounts Payable | $657K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $30M |
Total Non Current Liabilities | $2.2M |
Capital Lease Obligations | $2.8M |
Long Term Debt | - |
Current Long Term Debt | $29M |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $32M |
Other Current Liabilities | -$651M |
Other Non Current Liabilities | - |
Total Shareholder Equity | -$2.5M |
Treasury Stock | - |
Retained Earnings | -$255M |
Common Stock | $11K |
Common Stock Shares Outstanding | $9.7M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$34M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $1.2M |
Capital Expenditures | $55K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | -$16M |
Cashflow From Financing | $31M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $62M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | $40M |
Field | Value (USD) |
---|---|
Gross Profit | -$3M |
Total Revenue | $3M |
Cost Of Revenue | $6M |
Costof Goods And Services Sold | $6M |
Operating Income | -$44M |
Selling General And Administrative | $25M |
Research And Development | $5.9M |
Operating Expenses | $41M |
Investment Income Net | - |
Net Interest Income | $209K |
Interest Income | $254K |
Interest Expense | $45K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $1.2M |
Income Before Tax | $28M |
Income Tax Expense | -$3.5B |
Interest And Debt Expense | - |
Net Income From Continuing Operations | $28M |
Comprehensive Income Net Of Tax | - |
Ebit | $28M |
Ebitda | $30M |
Net Income | $40M |
Sector: LIFE SCIENCES
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
PAVmed Inc. is a medical device company in the United States. The company is headquartered in New York, New York.